80 results

• FDA Adds Veozah Liver Injury Warnings in “Black Box” on Menopause Drug’s Label

  December 18, 2024

  Irvin Jackson

  Side effects of Veozah have been linked to reports of rare, but serious liver injuries, leading to new warnings that urge users to stop taking the menopause drug if they experience symptoms of liver problems, like jaundice.

• FDA Warns of Ocaliva Liver Injury Risks Linked to Autoimmune Disorder Drug

  December 13, 2024

  Martha Garcia

  Federal regulators warns that the autoimmune treatment Ocaliva has been linked to liver damage and failure, resulting in patient deaths and the need for transplants.

• Veozah Side Effects Linked to Severe Liver Injury Risks: FDA

  September 13, 2024

  Irvin Jackson

  The FDA warns that the menopause drug Veozah may cause severe liver injuries, and is calling for doctors to conduct additional liver testing for patients using the medication.

• Researchers Have Developed New Way To Identify Liver Side Effects of Medications

  June 26, 2024

  Martha Garcia

  In a new study, researchers have identified a more accurate approach to measuring rates of liver injury, which revealed a number of drugs that could cause liver side effects that were previously viewed as safe.

• Lawsuit Alleges Contaminated Water at Camp Lejeune Caused Fatty Liver Disease

  May 9, 2023

  Irvin Jackson

  A Marine once stationed at Camp Lejeune has filed a lawsuit claiming contaminated water on the base led to the development of fatty liver disease.

• Limiting Acetaminophen in Opioids Led to Less Liver Failure and Toxicity Injuries, Researchers Find

  March 13, 2023

  Russell Maas

  A new study finds that an FDA mandate limiting acetaminophen in opioids may have led to significant reductions in liver toxicity cases nationwide.

• Prenatal PFAS Exposure Increases Risk Of Liver Injury To Newborns: Study

  August 6, 2020

  Irvin Jackson

  A new study links PFAS exposure during pregnancy to an increased risk of childhood liver damage.

• Ocaliva Dosing Problems Lead To FDA Black Box Warning

  February 2, 2018

  Irvin Jackson

  The FDA is adding a new black box label warning to labels of Ocaliva, following reports of at least 19 deaths linked to incorrect dosing and severe liver injury.

• Limbrel Recall Issued Over Liver Injury Risks

  January 31, 2018

  Irvin Jackson

  A Limbrel recall comes about a month after the FDA began pressuring Primus Pharmaceuticals to remove the osteoarthritis medical food products from the market following reports of liver injury and hypersensitivity.

• Limbrel Side Effects Linked To Liver Injury Risks, FDA Warns

  December 6, 2017

  Irvin Jackson

  The FDA is urging consumers not to use Limbrel, capsules marketed as medical food for the treatment of osteoarthritis, due to liver and hypersensitivity risks. It has also called for a Limbrel recall, but the manufacturer has so far refused to comply.